Estimation of Atherogenic Index of Plasma, Prolactin, and Some Other Hormones in Polycystic Ovarian Syndrome in Lean Women
DOI:
https://doi.org/10.14500/aro.12406Keywords:
Atherogenic index of plasma, Prolactin, Luteinizing hormone, Follicle-stimulating hormoneAbstract
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder with an increase in androgen levels that influences young women during reproductive age, and it is associated with different reproductive health issues and has significant influences on metabolic pathways. This study focused on the estimation of the atherogenic index of plasma (AIP), LDL/ HDL ratio, Prolactin, and some other parameters that influenced lean women with PCOS. A total of 120 women from Shahid Doctor Khalid Hospital (Koya health centers) in Koya-Erbil Governorate, aged from 25 to 45 years, were distributed into 90 lean women patients with PCOS and 30 healthy individuals who have no PCOS as control groups. This work revealed that the parameters of serum Prolactin, LH, FSH, TSH, Testo, insulin, FBG and HOMA-IR were significantly elevated in lean women with PCOS groups as compared with normal groups. The lipid profile parameters of serum T-Chol, TG, LDL, and VLDL were significantly higher in the PCOS group when compared with healthy individuals, whereas the serum level of HDL was significantly decreased in the PCOS group compared to healthy persons. No significant difference was found for serum Mg among PCOS and control groups. This study indicates from the calculation of BMI (kg/m2) that women with PCOS have normal body weight. AIP is detected as a useful biomarker to indicate the cardiovascular disease (CVD) risk in the future. The results of this study indicate that those lean women with PCOS have insulin resistance (IR) due to the high levels of HOMA-IR.
Downloads
References
Al-Moayad, H.A.A-Q., Alezzi, JI., and Mohammed, A.S., 2024. Association of spexin hormone levels with metabolic disturbance in women with polycystic ovarian syndrome. Diyala Journal of Medicine, 27, pp.12-24. DOI: https://doi.org/10.26505/djm.v27i1.1138
Anik Ilhan, G., Yildizhan, B., and Pekin, T., 2019. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. Gynecological Endocrinology, 35, pp.233-236. DOI: https://doi.org/10.1080/09513590.2018.1519794
Assani, M.Z., Novac, M.B., Dijmărescu, A.L., Văduva, C.C., Vladu, I.M., Clenciu, D., Mitrea, A., Ahrițculesei, R.V., Stroe-Ionescu, A.Ș., Assani, A.D., Caragea, D.C., Boldeanu, M.V., Siloși, I., and Boldeanu, L., 2025. Potential association between atherogenic coefficient, prognostic nutritional index, and various obesity indices in diabetic nephropathy. Nutrients, 17, p.1339. DOI: https://doi.org/10.3390/nu17081339
Cela, E., De Alcubierre, D., and Sbardella, E., 2025. Polycystic ovary syndrome in the context of pituitary adenomas: Prevalence, pathophysiology and clinical management. Clinical Endocrinology, 102, pp.462-481. DOI: https://doi.org/10.1111/cen.15182
Chang, K.J., Chen, J.H., and Chen, K.H., 2024. The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: A molecular and cellular review of the literature. International Journal of Molecular Sciences, 25, p.9037. DOI: https://doi.org/10.3390/ijms25169037
Corona, G., Rastrelli, G., Bianchi, N., Sparano, C., Sforza, A., Vignozzi, L., and Maggi, M., 2024. Hyperprolactinemia and male sexual function: Focus on erectile dysfunction and sexual desire. International Journal of Impotence Research, 36, pp.324-332. DOI: https://doi.org/10.1038/s41443-023-00717-1
Davoudi, Z., Araghi, F., Vahedi, M., Mokhtari, N., and Gheisari, M., 2021. Prolactin level in polycystic ovary syndrome (PCOS): An approach to the diagnosis and management. Acta Bio Medica Atenei Parmensis, 92, p.e2021291.
Decrinis, C., Hofmann, K., Bitterlich, N., Singer, A., Tropschuh, K., LozzaFiaco, S., Estermann, J., Bachmann, A., and Stute, P., 2025. Sleep disorders and psychological comorbidities in women with polycystic ovary syndrome-a cross-sectional study. Archives of Gynecology and Obstetrics, 312, pp.573-582. DOI: https://doi.org/10.1007/s00404-025-08049-9
Deli, D.A., Almammory, G.K., and Obaid, K.M., 2024. Assessment of thyroid stimulating hormone, triiodothyronine, luteinizing hormone and folliclestimulating hormone levels in polycystic ovary syndrome. Medical Science Journal for Advance Research, 5, pp.1-8.
Glintborg, D., Altinok, M., Mumm, H., Buch, K., Ravn, P., and Andersen, M., 2014. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome. Human Reproduction, 29, pp.1773-1779. DOI: https://doi.org/10.1093/humrep/deu133
Hajian-Tilaki, K., 2014. Sample size estimation in diagnostic test studies of biomedical informatics. Journal of Biomedical Informatics, 48, pp.193-204. DOI: https://doi.org/10.1016/j.jbi.2014.02.013
Hamad, S.S., and Ahmed, S.N., 2025. Determination of insulin resistance, adiponectin and leptin in overweight women with polycystic ovarian syndrome. Middle East Fertility Society Journal, 30, p.29. DOI: https://doi.org/10.1186/s43043-025-00243-8
Hamadameen, B.K., and Hamad, S.S., 2023. Atherogenic index of plasma in the three trimesters of pregnancy. Aro the Scientific Journal of Koya University, 11, pp.151-156. DOI: https://doi.org/10.14500/aro.11337
Hofman, A., Breteler, M.M., Van Duijn, C.M., Krestin, G.P., Pols, H.A., Stricker, B.H.C., Tiemeier, H., Uitterlinden, A.G., Vingerling, J.R., and Witteman, J.C., 2007. The rotterdam study: Objectives and design update. European Journal of Epidemiology, 22, pp.819-829. DOI: https://doi.org/10.1007/s10654-007-9199-x
Imannezhad, M., Kamrani, F., Shariatikia, A., Nasrollahi, M., Mahaki, H., Rezaee, A., Moohebati, M., Shahri, S.H.H., and Darroudi, S., 2025. Association of atherogenic indices and triglyceride-total cholesterol-body weight index (TCBI) with severity of stenosis in patients undergoing angiography: A casecontrol study. BMC Research Notes, 18, p.180. DOI: https://doi.org/10.1186/s13104-025-07203-5
Kaune, H., Montiel, J.F., Fenwick, M., and Williams, S.A., 2022. Rapid ovarian transcript changes during the onset of premature ovarian insufficiency. Reproduction and Fertility, 3, pp.173-186. DOI: https://doi.org/10.1530/RAF-22-0036
Kaur, R., and Kaur, M., 2024. Evaluation of potential association of metabolic syndrome in obese and non-obese PCOS women. Middle East Fertility Society Journal, 29, p.9. DOI: https://doi.org/10.1186/s43043-024-00170-0
Kheirollahi, A., Teimouri, M., Karimi, M., Vatannejad, A., Moradi, N., Borumandnia, N., and Sadeghi, A., 2020. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids in Health and Disease, 19, p.235. DOI: https://doi.org/10.1186/s12944-020-01410-8
Kulik-Kupka, K., Jabczyk, M., Nowak, J., Jagielski, P., Hudzik, B., and Zubelewicz-Szkodzińska, B., 2022. Fetuin-A and its association with anthropometric, atherogenic, and biochemical parameters and indices among women with polycystic ovary syndrome. Nutrients, 14, p.4034. DOI: https://doi.org/10.3390/nu14194034
Parveen, S., Khan, S., Khan, M.M., Gupta, B., Ahmad, A., and Alam, R., 2024. Association of lipid profile and obesity in patients with polycystic ovary syndrome. Endocr Regul, 58, p.83-90. DOI: https://doi.org/10.2478/enr-2024-0009
Saadia, Z., 2020. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs. Non-obese women. Medical Archives, 74, pp.289-293. DOI: https://doi.org/10.5455/medarh.2020.74.289-293
Shah, A.K., Yadav, B.K., Shah, A.K., Suri, A., and Deo, S.K., 2023. Cardiovascular risk predictors high sensitivity C-reactive protein and plasminogen activator inhibitor-1 in women with lean phenotype of polycystic ovarian syndrome: A prospective case-control study. Journal of Laboratory Physicians, 15, pp.031-037. DOI: https://doi.org/10.1055/s-0042-1750066
Suchta, K., Zeber-Lubecka, N., Grymowicz, M., Smolarczyk, R., Kulecka, M., and Hennig, E.E., 2025. Autoimmune processes and chronic inflammation as independent risk factors for metabolic complications in women with polycystic ovary syndrome. Metabolites, 15, p.141. DOI: https://doi.org/10.3390/metabo15030141
Ulutaş, F., Cander, S., and Gül, Ö.Ö., 2022. The association between triglycerides/ high-density lipoprotein cholesterol ratio, insulin resistance, and serum androgen levels in patients with polycystic ovary syndrome. The European Research Journal, 8, pp.275-281. DOI: https://doi.org/10.18621/eurj.1064555
Uysal, E., Tammo, O., Soylemez, E., Incebıyık, M., Filiz, D., and Alci, M., 2024. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome. BMC Endocrine Disorders, 24, p.160. DOI: https://doi.org/10.1186/s12902-024-01701-6
Wang, R., and Mol, B.W.J., 2017. The rotterdam criteria for polycystic ovary syndrome: Evidence-based criteria? Human Reproduction, 32, pp.261-264. DOI: https://doi.org/10.1093/humrep/dew287
Yang, H., Di, J., Pan, J., Yu, R., Teng, Y., Cai, Z., and Deng, X., 2020. The association between prolactin and metabolic parameters in PCOS women: A retrospective analysis. Frontiers in Endocrinology, 11, p.263. DOI: https://doi.org/10.3389/fendo.2020.00263
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sara S. Hamad, Sardar N. Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who choose to publish their work with Aro agree to the following terms:
-
Authors retain the copyright to their work and grant the journal the right of first publication. The work is simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0]. This license allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
-
Authors have the freedom to enter into separate agreements for the non-exclusive distribution of the journal's published version of the work. This includes options such as posting it to an institutional repository or publishing it in a book, as long as proper acknowledgement is given to its initial publication in this journal.
-
Authors are encouraged to share and post their work online, including in institutional repositories or on their personal websites, both prior to and during the submission process. This practice can lead to productive exchanges and increase the visibility and citation of the published work.
By agreeing to these terms, authors acknowledge the importance of open access and the benefits it brings to the scholarly community.
Accepted 2025-10-03
Published 2025-11-07
ARO Journal is a scientific, peer-reviewed, periodical, and diamond OAJ that has no APC or ASC.